Takeda Escapes FCA Suit Over Undisclosed Drug Complications
A Massachusetts federal judge on Thursday stamped out False Claims Act allegations from an ex-contractor at Takeda Pharmaceutical Co. Ltd., saying the company's failure to disclose serious complications involving diabetes drug...To view the full article, register now.
Already a subscriber? Click here to view full article